封面
市場調查報告書
商品編碼
1390475

自然殺手細胞治療市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Natural Killer Cells Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年,全球自然殺手細胞治療市場規模達到25億美元。展望未來, IMARC Group預計到2028年市場規模將達到54億美元,2022-2028年複合年成長率(CAGR)為13.70%。

自然殺手 (NK) 細胞療法針對多種致病抗原,具有高效的細胞毒性,並降低細胞激素風暴的風險。它們可以從多種來源生產,而不依賴患者特異性免疫細胞。目前,已經開發了多種策略,例如用細胞激素或小分子藥物進行體外預處理以及設計嵌合抗原受體(CAR)NK,從而提高NK細胞治療的功效。此外,研究人員正致力於透過強大的擴增、增強的靶向性和延長強效免疫細胞的持久性來最大化同種異體 NK 細胞的治療效果。這也有助於釋放強大而持續的抗癌免疫介導攻擊。

自然殺手細胞治療市場趨勢:

患有癌症、傳染病和肝臟疾病的人數顯著增加是推動市場成長的主要因素之一。這可歸因於不健康的飲食模式、缺乏體力活動、日益嚴重的空氣污染以及越來越多的人消費酒精和菸草產品。此外,隨著年齡的成長,罹患癌症的風險急劇上升,全球不斷增加的老年人口正在成為另一個生長誘導因素,催化對 NK 細胞療法的需求。除此之外,由於癌症患者的免疫反應不足,醫療公司正在開發新的方法和技術,透過同種異體、現成的 NK 細胞療法來增強免疫反應。此外,專注於腫瘤靶向抗體策略的臨床研究數量增加,以增強基於 NK 細胞的療法的治療效果,同時最大限度地降低風險和毒性。此外,許多國家的管理機構正在為癌症患者的財務計劃提供資金,這為市場創造了良好的前景。

本報告回答的關鍵問題

  • 2022 年全球自然殺手細胞治療市場規模有多大?
  • 2023-2028年全球自然殺手細胞治療市場的預期成長率是多少?
  • 推動全球自然殺手細胞治療市場的關鍵因素是什麼?
  • COVID-19 對全球自然殺手細胞治療市場有何影響?
  • 基於療法的全球自然殺手細胞療法市場的細分是什麼?
  • 基於應用的全球自然殺手細胞治療市場的詳細情形如何?
  • 基於最終用戶的全球自然殺手細胞治療市場的詳細情形如何?
  • 全球自然殺手細胞治療市場的關鍵區域有哪些?
  • 誰是全球自然殺手細胞治療市場的主要參與者/公司?

目錄

第 1 章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球自然殺手細胞治療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:治療領域的市場區隔

  • NK 細胞療法
    • 市場走向
    • 市場預測
  • NK 細胞定向抗體
    • 市場走向
    • 市場預測

第 7 章:按應用分類的市場區隔

  • 癌症
    • 市場走向
    • 市場預測
  • 胃腸道疾病
    • 市場走向
    • 市場預測
  • 免疫增生性疾病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章:最終用戶的市場區隔

  • 醫院
    • 市場走向
    • 市場預測
  • 研究中心和研究所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章:按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章:價值鏈分析

第 12 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章:價格分析

第14章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Affimed GmbH
    • Bristol-Myers Squibb Company
    • Fate Therapeutics
    • Fortress Biotech Inc.
    • Glycostem Therapeutics
    • Innate Pharma SA
    • Kuur Therapeutics Inc. (Athenex Inc.)
    • Nkarta Inc.
    • Takeda Pharmaceutical Company Limited
    • Ziopharm Oncology Inc.
Product Code: SR112023A4214

Abstract

The global natural killer cells therapeutics market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.4 Billion by 2028, exhibiting a growth rate (CAGR) of 13.70% during 2022-2028.

Natural killer (NK) cells therapeutics target multiple pathogenic antigens with efficient cytotoxicity and reduce the risk of cytokine storms. They can be produced from a variety of sources without relying on patient-specific immune cells. At present, several strategies have been developed, such as ex vivo pre-conditioning with cytokines or small molecular drugs and engineering a chimeric antigen receptor (CAR) NK, which improve the efficacy of NK cells therapeutics. Moreover, researchers are focusing on maximizing the therapeutic effects of allogeneic NK cells through robust expansion, enhanced targeting, and extended persistence of potent immune cells. This can also help unleash a strong and sustained anti-cancer immune-mediated attack.

Natural Killer Cells Therapeutics Market Trends:

A significant rise in the number of individuals with cancer, infectious diseases, and liver disorders represents one of the primary factors fueling the market growth. This can be attributed to unhealthy dietary patterns, lack of physical activities, growing air pollution, and the increasing number of individuals consuming alcohol and tobacco products. Moreover, as the risk of developing cancer rises dramatically with age, the increasing geriatric population across the globe is acting as another growth-inducing factor catalyzing the demand for NK cells therapeutics. Apart from this, as the immune response of cancer patients is not adequate, health companies are developing novel methods and technologies to boost the immune response through allogeneic, off-the-shelf NK cell-based therapies. Furthermore, there is a rise in the number of clinical studies that focus on tumor-targeted antibody strategies to enhance the therapeutic benefit of NK-cell-based therapy while minimizing risks and toxicities. In addition, governing agencies of numerous countries are funding financial schemes for cancer patients, which is creating a favorable outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global natural killer cells therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapeutics, application and end user.

Breakup by Therapeutics:

NK Cell Therapies

NK Cell Directed Antibodies

Breakup by Application:

Cancer

Gastrointestinal Diseases

Immunoproliferative Disorders

Others

Breakup by End User:

Hospitals

Research Centers and Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Affimed GmbH, Bristol-Myers Squibb Company, Fate Therapeutics, Fortress Biotech Inc., Glycostem Therapeutics, Innate Pharma S.A., Kuur Therapeutics Inc. (Athenex Inc.), Nkarta Inc., Takeda Pharmaceutical Company Limited and Ziopharm Oncology Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global natural killer cells therapeutics market in 2022?
  • 2. What is the expected growth rate of the global natural killer cells therapeutics market during 2023-2028?
  • 3. What are the key factors driving the global natural killer cells therapeutics market?
  • 4. What has been the impact of COVID-19 on the global natural killer cells therapeutics market?
  • 5. What is the breakup of the global natural killer cells therapeutics market based on the therapeutics?
  • 6. What is the breakup of the global natural killer cells therapeutics market based on the application?
  • 7. What is the breakup of the global natural killer cells therapeutics market based on the end user?
  • 8. What are the key regions in the global natural killer cells therapeutics market?
  • 9. Who are the key players/companies in the global natural killer cells therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Natural Killer Cells Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutics

  • 6.1 NK Cell Therapies
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 NK Cell Directed Antibodies
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gastrointestinal Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunoproliferative Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Centers and Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Affimed GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Bristol-Myers Squibb Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Fate Therapeutics
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Fortress Biotech Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Glycostem Therapeutics
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Innate Pharma S.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Kuur Therapeutics Inc. (Athenex Inc.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Nkarta Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Takeda Pharmaceutical Company Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Ziopharm Oncology Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials

List of Figures

  • Figure 1: Global: Natural Killer Cells Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Natural Killer Cells Therapeutics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Natural Killer Cells Therapeutics Market: Breakup by Therapeutics (in %), 2022
  • Figure 5: Global: Natural Killer Cells Therapeutics Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Natural Killer Cells Therapeutics Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Natural Killer Cells Therapeutics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Natural Killer Cells Therapeutics (NK Cell Therapies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Natural Killer Cells Therapeutics (NK Cell Therapies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Natural Killer Cells Therapeutics (NK Cell Directed Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Natural Killer Cells Therapeutics (NK Cell Directed Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Natural Killer Cells Therapeutics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Natural Killer Cells Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Natural Killer Cells Therapeutics (Gastrointestinal Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Natural Killer Cells Therapeutics (Gastrointestinal Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Natural Killer Cells Therapeutics (Immunoproliferative Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Natural Killer Cells Therapeutics (Immunoproliferative Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Natural Killer Cells Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Natural Killer Cells Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Natural Killer Cells Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Natural Killer Cells Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Natural Killer Cells Therapeutics (Research Centers and Institutes ) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Natural Killer Cells Therapeutics (Research Centers and Institutes ) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Natural Killer Cells Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Natural Killer Cells Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Natural Killer Cells Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Natural Killer Cells Therapeutics Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Natural Killer Cells Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Natural Killer Cells Therapeutics Industry: SWOT Analysis
  • Figure 76: Global: Natural Killer Cells Therapeutics Industry: Value Chain Analysis
  • Figure 77: Global: Natural Killer Cells Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Natural Killer Cells Therapeutics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by Therapeutics (in Million US$), 2023-2028
  • Table 3: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Natural Killer Cells Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Natural Killer Cells Therapeutics Market: Competitive Structure
  • Table 7: Global: Natural Killer Cells Therapeutics Market: Key Players